CRBP P/E Ratio
P/E Ratio as of Jun 20, 2025: -1.95
Average-1.94
Median-1.96
Minimum-2.19
Maximum-1.71
-1.95
Past Month-0.11 (5.98%)
The P/E ratio for CRBP is -1.95 as of Jun 20, 2025. This represents a decrease of -52.67% compared to its 12-month average P/E ratio of -4.12. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Corbus Pharmaceuticals Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Corbus Pharmaceuticals Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Corbus Pharmaceuticals Holdings to industry peers.
Corbus Pharmaceuticals Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Corbus Pharmaceuticals Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Corbus Pharmaceuticals Holdings to industry peers.
CRBP P/E Ratio Insights
See Corbus Pharmaceuticals Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CRBP
Order type
Buy in
Order amount
Est. shares
0 shares
CRBP P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $7.34 | -1.74 |
| May 1, 2025 | $7.52 | -2.05 |
| Apr 1, 2025 | $5.03 | -1.37 |
| Mar 3, 2025 | $6.96 | -1.48 |
| Feb 3, 2025 | $9.51 | -2.03 |
| Jan 2, 2025 | $12.04 | -2.56 |
CRBP End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.95 | -22.31% |
| 2024 | -2.51 | +364.81% |
| 2023 | -0.54 | +63.64% |
| 2022 | -0.33 | -79.38% |
| 2021 | -1.60 | +88.24% |
| 2020 | -0.85 | — |
FAQs About Corbus Pharmaceuticals Holdings (CRBP) P/E ratio
The latest P/E ratio of CRBP is -1.95, as of Jun 20, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Corbus Pharmaceuticals Holdings’s last 12-month average P/E ratio is -4.12, compared to its current P/E ratio of -1.95. This reflects a decrease of -52.67%.
Corbus Pharmaceuticals Holdings’s current P/E ratio of -1.95 is lower than its last 12-month average P/E of -4.12. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Corbus Pharmaceuticals Holdings’s average P/E ratio over the last 3 years is -2.34. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Corbus Pharmaceuticals Holdings’s average P/E ratio over the last 5 years is -2.17. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.